International Biotechnology Trust: star stocks and Covid vaccine race

What are the origins of innovation in biotech? Investment manager Ailsa Craig on where great firms begin.

22nd October 2020 10:07

by Richard Hunter from interactive investor

Share on

What are the origins of innovation in biotech? Ailsa Craig, investment manager of the International Biotechnology Trust (LSE:IBT), discusses where great companies begin, US election outcomes, and why the outlook for the sector is a sunny one.

  • Listen to more interactive investor podcasts featuring our own investment experts, fund managers and industry commentators by visiting our podcast page.

These articles are provided for information purposes only.  Occasionally, an opinion about whether to buy or sell a specific investment may be provided by third parties.  The content is not intended to be a personal recommendation to buy or sell any financial instrument or product, or to adopt any investment strategy as it is not provided based on an assessment of your investing knowledge and experience, your financial situation or your investment objectives. The value of your investments, and the income derived from them, may go down as well as up. You may not get back all the money that you invest. The investments referred to in this article may not be suitable for all investors, and if in doubt, an investor should seek advice from a qualified investment adviser.

Full performance can be found on the company or index summary page on the interactive investor website. Simply click on the company's or index name highlighted in the article.

Related Categories

    Investment TrustsPodcasts

Get more news and expert articles direct to your inbox